Project Grant HT94252510920
- The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
- The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
- This Project Grant award for $318,483.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The funding will support a 2-year research project to quantitatively measure acute and chronic lesion activity in a real-world, multisite clinical MRI dataset. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
- The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...
- The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
- This Project Grant award of $319,240.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to characterize the microRNAs (miRNAs) involved in regulating human oligodendrocyte maturation and myelin formation. The grant was awarded to The Johns Hopkins University, a renowned private, non-profit research institution, on September 1, 2025, with a completion date of August 31, 2027. This research aims to transform healthcare for military...
- The U.S. Defense Health Agency awarded a $1,553,332 Project Grant to The Johns Hopkins University on October 1, 2025 through the Military Medical Research and Development (CFDA 12.420) program. The grant funding will support advanced biomedical research to investigate the impact of breast tissue microbiota on breast cancer progression over a 3-year performance period. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
- The Johns Hopkins University was awarded a $1,407,634 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The 3-year grant, awarded on September 1, 2025, will fund the "BLAST-EXPOSURE OUTCOMES AND ASSOCIATED LONG-TERM SYMPTOM TRAJECTORIES RELATED TO ESSENTIAL RECOVERY-PATHWAYS (BOLSTER) BIOMARKER INITIATIVE" research project. This advanced biomedical research effort aims to transform healthcare for military service...
This $320,165 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by The Johns Hopkins University to investigate the social determinants of health, biological aging, and disease course in multiple sclerosis. The research aims to transform healthcare for military service members, veterans, and the broader public by pursuing innovative solutions to critical health challenges. As a leading federal contractor and grantee, The Johns Hopkins University has demonstrated extensive capabilities in biomedical research, medical innovation, and scientific discovery across various domains. The award period runs from October 1, 2025 to September 30, 2027, contributing to the program's strategy of funding diverse, multidisciplinary research initiatives with potential for near-term clinical applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $320.2k | 8/20/25 |